Published in Gut on August 01, 2003
Performance of platelet count/spleen diameter ratio for diagnosis of esophageal varices in cirrhosis: a meta-analysis. Dig Dis Sci (2012) 1.66
Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization. Dig Dis Sci (2006) 1.50
Thrombocytopenia and bleeding in veterans with non-hepatitis C-related chronic liver disease. Dig Dis Sci (2012) 1.42
Performance of the AST-to-platelet ratio index as a noninvasive marker of fibrosis in pediatric patients with chronic viral hepatitis. J Pediatr Gastroenterol Nutr (2010) 1.35
Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol (2014) 1.20
New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol (2006) 1.17
Right liver lobe/albumin ratio: contribution to non-invasive assessment of portal hypertension. World J Gastroenterol (2007) 1.07
Platelet count/bipolar spleen diameter ratio for the prediction of esophageal varices: The special Egyptian situation: Noninvasive prediction of esophageal varices. Hepat Mon (2011) 1.06
Predictors of esophageal varices in patients with HBV-related cirrhosis: a retrospective study. BMC Gastroenterol (2009) 1.04
Noninvasive prediction of large esophageal varices in chronic liver disease patients. Saudi J Gastroenterol (2010) 1.03
External validation of the platelet count/spleen diameter ratio for the diagnosis of esophageal varices in hepatitis C virus-related cirrhosis. Dig Dis Sci (2008) 1.02
Management of thrombocytopenia due to liver cirrhosis: a review. World J Gastroenterol (2014) 0.99
Assessment of portal hypertension and high-risk oesophageal varices with liver and spleen three-dimensional multifrequency MR elastography in liver cirrhosis. Eur Radiol (2014) 0.92
Chronic hepatitis C and liver fibrosis. World J Gastroenterol (2014) 0.92
Platelet count to spleen diameter ratio for the diagnosis of esophageal varices: Is it feasible? Can J Gastroenterol (2008) 0.90
A new sampling method for spleen stiffness measurement based on quantitative acoustic radiation force impulse elastography for noninvasive assessment of esophageal varices in newly diagnosed HCV-related cirrhosis. Biomed Res Int (2014) 0.90
Value of transient elastography for the prediction of variceal bleeding. World J Gastroenterol (2011) 0.90
Is transient elastography a useful tool for screening liver disease? World J Gastroenterol (2009) 0.90
Variceal hemorrhage: Saudi tertiary center experience of clinical presentations, complications and mortality. World J Hepatol (2012) 0.89
Non-invasive predictors of esophageal varices. Saudi J Gastroenterol (2011) 0.88
Personalized management of cirrhosis by non-invasive tests of liver fibrosis. Clin Mol Hepatol (2015) 0.87
Noninvasive evaluation of portal hypertension: emerging tools and techniques. Int J Hepatol (2012) 0.86
Platelet count/spleen diameter ratio to predict esophageal varices in Mexican patients with hepatic cirrhosis. World J Gastroenterol (2014) 0.85
Non-invasive prediction of oesophageal varices in cirrhosis. World J Gastroenterol (2008) 0.84
Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis. PLoS One (2015) 0.84
Liver stiffness measurement by fibroscan predicts the presence and size of esophageal varices in egyptian patients with HCV related liver cirrhosis. J Clin Diagn Res (2013) 0.84
Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension. World J Gastroenterol (2013) 0.84
Platelet count/spleen diameter ratio as a predictor of oesophageal varices in alcoholic cirrhosis. Gut (2004) 0.84
A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease. Clin Mol Hepatol (2012) 0.84
Use of the platelet count/spleen diameter ratio for the noninvasive diagnosis of esophageal varices in patients with schistosomiasis. Saudi J Gastroenterol (2011) 0.84
Portal hemodynamics as predictors of high risk esophageal varices in cirrhotic patients. World J Gastroenterol (2008) 0.83
Doppler surrogate endoscopy for screening esophageal varices in patients with cirrhosis. Hepat Mon (2014) 0.83
Noninvasive methods for prediction of esophageal varices in pediatric patients with portal hypertension. World J Gastroenterol (2013) 0.83
Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone. Gut (2004) 0.82
Gamna-Gandy bodies of the spleen detected with susceptibility weighted imaging: maybe a new potential non-invasive marker of esophageal varices. PLoS One (2013) 0.79
Usefulness of Noninvasive Predictors of Oesophageal Varices in Black African Cirrhotic Patients in Côte d'Ivoire (West Africa). Gastroenterol Res Pract (2012) 0.79
NT pro BNP plasma level and atrial volume are linked to the severity of liver cirrhosis. PLoS One (2013) 0.79
Platelet count/spleen diameter ratio predicted the presence of esophageal varices in liver cirrhosis. ACP J Club (2004) 0.78
Systemic abnormalities in liver disease. World J Gastroenterol (2009) 0.78
Portal venous flow pattern as a useful tool for predicting esophageal varix bleeding in cirrhotic patients. Dig Dis Sci (2005) 0.78
Multidetector computed tomography versus platelet/spleen diameter ratio as methods for the detection of gastroesophageal varices. Ann Gastroenterol (2016) 0.78
Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease. Springerplus (2016) 0.77
A novel model to predict esophageal varices in patients with compensated cirrhosis using acoustic radiation force impulse elastography. PLoS One (2015) 0.77
Management of Thrombocytopenia in Chronic Liver Disease: Focus on Pharmacotherapeutic Strategies. Drugs (2015) 0.77
Nitric oxide levels in chronic liver disease patients with and without oesophageal varices. Hepatol Int (2008) 0.76
Elastography for hepato-biliary-pancreatic surgery. Surg Today (2013) 0.76
Non-invasive prediction of esophageal varices: is it possible? Saudi J Gastroenterol (2011) 0.76
Coagulopathy in liver disease: Lack of an assessment tool. World J Gastroenterol (2015) 0.76
Platelet count/spleen diameter ratio: is there sufficient evidence for its use? Dig Dis Sci (2012) 0.75
Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis. World J Gastroenterol (2016) 0.75
Transient elastography can be integrated into routine clinical practice for the evaluation of portal hypertension? Clin Mol Hepatol (2017) 0.75
Platelet count combined with right liver volume and spleen volume measured by magnetic resonance imaging for identifying cirrhosis and esophageal varices. World J Gastroenterol (2015) 0.75
Post-gastrectomy spleen enlargement and esophageal varices: distal vs total gastrectomy. World J Gastroenterol (2010) 0.75
Role of spleen elastography in patients with chronic liver diseases. World J Gastroenterol (2016) 0.75
The Role of Spleen Stiffness in Determining the Severity and Bleeding Risk of Esophageal Varices in Cirrhotic Patients. Medicine (Baltimore) (2015) 0.75
Diagnostic non-invasive model of large risky esophageal varices in cirrhotic hepatitis C virus patients. World J Hepatol (2016) 0.75
Assessment of risk of complications in cirrhosis using portal thallium scans. World J Gastroenterol (2014) 0.75
Platelet Count to Spleen Diameter Ratio for the Diagnosis of Gastroesophageal Varices in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Gastroenterol Res Pract (2017) 0.75
Clinical role of non-invasive assessment of portal hypertension. World J Gastroenterol (2017) 0.75
Correlation of platelets count with endoscopic findings in a cohort of Egyptian patients with liver cirrhosis. Medicine (Baltimore) (2016) 0.75
Non-invasive Diagnosis of Oesophageal Varices Using Systemic Haemodynamic Measurements by Finometry: Comparison with Other Non-invasive Predictive Scores. J Clin Exp Hepatol (2016) 0.75
Towards noninvasive detection of oesophageal varices. Int J Hepatol (2012) 0.75
Infallibility of a normal platelet count/spleen diameter ratio in ruling out oesophageal varices? Gut (2004) 0.75
Predictors of esophageal varices and first variceal bleeding in liver cirrhosis patients. World J Gastroenterol (2017) 0.75
Geoepidemiology and changing mortality in primary biliary cholangitis. J Gastroenterol (2017) 0.75
The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology (1982) 79.76
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med (1996) 46.18
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Assessing the generalizability of prognostic information. Ann Intern Med (1999) 8.04
Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA (1997) 7.71
Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health (2000) 3.82
The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33
The treatment of portal hypertension: a meta-analytic review. Hepatology (1995) 3.11
To scope or not to scope: still a question. Hepatology (2001) 2.57
Prediction of esophageal varices in patients with cirrhosis. J Clin Gastroenterol (2002) 2.45
The natural history of cirrhosis. I. Survival with esophageal varices. N Engl J Med (1963) 2.41
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology (2001) 1.99
Risk factors for the presence of varices in cirrhotic patients without a history of variceal hemorrhage. Arch Intern Med (2001) 1.96
Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol (1999) 1.93
Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis (2001) 1.91
Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol (1999) 1.77
Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74
Thrombocytopenia in liver disease. Can J Gastroenterol (2000) 1.64
Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol (1997) 1.60
Non-invasive diagnosis of esophageal varices in chronic liver diseases. J Hepatol (1999) 1.47
Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology (2002) 1.45
Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol (1992) 1.27
Examiner dependence on physical diagnostic tests for the detection of splenomegaly: a prospective study with multiple observers. J Gen Intern Med (1993) 1.25
Aspects of the natural history of gastrointestinal bleeding in cirrhosis and the effect of prednisone. Gastroenterology (1981) 1.25
Prediction of oesophagogastric varices in patients with liver cirrhosis. J Gastroenterol Hepatol (1999) 1.18
Qualitative hepatic venous Doppler sonography versus portal flowmetry in predicting the severity of esophageal varices in hepatitis C cirrhosis. AJR Am J Roentgenol (1997) 1.10
Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. Gut (1990) 1.02
Endoscopic screening for esophageal varices in cirrhotic patients. Hepatology (2002) 0.99
A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices. Gastrointest Endosc (1992) 0.99
Correlation between splenomegaly and oesophageal varices in patients with liver cirrhosis. Endoscopy (1994) 0.98
Prediction of varices in patients with cirrhosis: a high-stakes numbers game? J Clin Gastroenterol (2002) 0.93
Liver cirrhosis: epidemiological aspects in Italy. Res Virol (1997) 0.90
Clinical predictors of large esophageal varices: how accurate are they? Am J Gastroenterol (1999) 0.89
Portal hypertension and esophageal varices in cystic fibrosis. Unreliability of echo-Doppler flowmetry. Scand J Gastroenterol (1993) 0.89
Health care costs associated with chronic hepatitis B. Am J Health Syst Pharm (1999) 0.87
A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med (1995) 3.98
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. Aliment Pharmacol Ther (2014) 2.27
Physiology of growth and sporulation in Bacillus cereus. I. Effect of glutamic and other amino acids. J Bacteriol (1966) 2.02
Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epi-doxorubicin, 6S-leucovorin, glutathione, and filgrastim: a report from the Italian Group for the Study of Digestive Tract Cancer. J Clin Oncol (1997) 1.94
Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. Eur Heart J (1999) 1.92
Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest (2003) 1.86
Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients. Am J Gastroenterol (1993) 1.74
Raman spectroscopy of graphene edges. Nano Lett (2009) 1.67
Control of the citric acid cycle by glyoxylate. Mechanism of the inhibition by oxalomalate and gamma-hydroxy-alpha-oxoglutarate. Biochem J (1967) 1.58
+647 A/C and +1245 MT1A polymorphisms in the susceptibility of diabetes mellitus and cardiovascular complications. Mol Genet Metab (2008) 1.56
Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems. J Intern Med (2004) 1.53
Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. Aliment Pharmacol Ther (2003) 1.52
Influence of mastication on gastric emptying. J Dent Res (2002) 1.50
Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. Am J Gastroenterol (1999) 1.50
Selection of T cell epitopes and vaccine engineering. Methods Enzymol (1991) 1.50
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn. Aliment Pharmacol Ther (2004) 1.49
Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. Circulation (2000) 1.49
Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut (2009) 1.49
Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection? J Clin Gastroenterol (1996) 1.44
Transportability and reproducibility of the AST/ALT ratio in chronic hepatitis C patients. Am J Gastroenterol (2001) 1.44
Circadian pattern of intragastric acidity in patients with non-erosive reflux disease (NERD). Aliment Pharmacol Ther (2003) 1.44
Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations? Dig Liver Dis (2006) 1.42
Control of the differentiation state and function of human epidermal Langerhans cells by cytokines in vitro. J Eur Acad Dermatol Venereol (2001) 1.41
Early apoptosis plays an important role in the healing mechanism of cutaneous basal cell carcinomas after photodynamic therapy. Br J Dermatol (2003) 1.39
H2 antagonist and omeprazole nonresponders. Dig Dis Sci (1991) 1.39
[Synthesis of 3-hydrazino-pyridazines with basic substituents in 6 positions, with hypotensive activity]. Farmaco Sci (1969) 1.39
Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection. Ital J Gastroenterol Hepatol (1999) 1.38
Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J (1993) 1.36
[Ultrastructure of the tunica muscularis of the cardial portion of the human esophagus and stomach, with special reference to the so-called Cajal's interstitial cells]. Arch Ital Anat Embriol (1977) 1.26
Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet. Dig Liver Dis (2006) 1.26
2,6-Dialkylpiperazines. V. Synthesis of 2,6-alkylpiperazine derivatives structurally related to cinnarazine. J Med Chem (1968) 1.23
Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation (1993) 1.21
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy. Pharmacogenomics J (2007) 1.20
Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol (1991) 1.20
Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig Dis Sci (1999) 1.18
Increased expression of endothelin in bronchial epithelial cells of asthmatic patients and effect of corticosteroids. Am Rev Respir Dis (1992) 1.18
HLA polymorphism and T cell recognition of a conserved region of p190, a malaria vaccine candidate. Int Immunol (1991) 1.16
Serum leptin levels in patients with viral chronic hepatitis or liver cirrhosis. J Hepatol (2000) 1.16
A review of the role of soluble fiber in health with specific reference to wheat dextrin. J Int Med Res (2009) 1.14
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14
A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer. Ann Oncol (2000) 1.13
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2011) 1.12
Levels of endothelin in the bronchoalveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J Allergy Clin Immunol (1991) 1.10
Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology (1992) 1.09
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up. Dig Liver Dis (2005) 1.09
Sustained virological response to pegylated interferon and ribavirin is maintained during long-term follow-up of chronic hepatitis C patients. Aliment Pharmacol Ther (2009) 1.09
Experimental atherosclerosis in the rat: biochemical evaluation. J Pharm Pharmacol (1975) 1.08
Oral keratinocyte immune responses in HIV-associated candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1997) 1.08
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori. Aliment Pharmacol Ther (1999) 1.08
Evaluation of blood pressure/height ratio as an index to simplify diagnostic criteria of hypertension in Caucasian adolescents. J Hum Hypertens (2011) 1.08
Mean and median of pH values, characterizing average intragastric acidity. Am J Gastroenterol (1989) 1.06
Letter: Treatment for small intestinal bacterial overgrowth--where are we now? Aliment Pharmacol Ther (2014) 1.06
Cytokine gene polymorphisms in recurrent pregnancy loss of unknown cause. Am J Reprod Immunol (2004) 1.06
Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review. Dig Liver Dis (2004) 1.06
Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer. J Clin Endocrinol Metab (2000) 1.05
Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole. Gastrointest Endosc (1996) 1.05
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol (1998) 1.05
Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs. Ann Oncol (2004) 1.04
Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2010) 1.04
Clinical trial: ulcerative colitis maintenance treatment with 5-ASA: a 1-year, randomized multicentre study comparing MMX with Asacol. Aliment Pharmacol Ther (2009) 1.03
Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients. Br J Cancer (2002) 1.03
Medial patellofemoral ligament anatomy: implications for its surgical reconstruction. Knee Surg Sports Traumatol Arthrosc (2009) 1.02
The impact of antibiotic resistance on the efficacy of three 7-day regimens against Helicobacter pylori. Aliment Pharmacol Ther (2000) 1.02
Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Mol Biol (1990) 1.02
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit? Br J Cancer (2008) 1.01
Mucosal cytokine and antigen-specific responses to Cryptosporidium parvum in IL-12p40 KO mice. Parasite Immunol (2005) 1.01
Gastric histology and fasting bile reflux after partial gastrectomy. Gastroenterology (1987) 1.00
Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? Hepatogastroenterology (2001) 1.00